Core Laboratories N.V. · Amsterdam The Netherlands (NYSE: CLB)
Key Core Laboratories N.V. Financials
| Company Type | Public -(NYSE: CLB) Headquarters |
|---|---|
| Fiscal Year-End | December |
| Sales (mil.) | $303.7 |
| 2010 Employees | 5,000 |
Core Laboratories N.V. Stock Quote (NYSE: CLB)
| Latest 02/15/12 16:02:14 EST | Change ($) | Change (%) | High | Low |
|---|---|---|---|---|
| $119.86 | 0.000 | 0.000 | $0.00 | $0.00 |
Quotes delayed 15 minutes for NASDAQ, 20 minues for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions. |
Core Laboratories N.V. Income Statement
| Dec 99 | Dec 94 | Dec 93 | |
| Revenue | 303.7 | 69.4 | 69.9 |
| Cost of Goods Sold | 245.5 | -- | -- |
| Gross Profit | 58.2 | 69.4 | 69.9 |
| Gross Profit Margin | 19.2% | -- | -- |
| SG&A Expense | 12.3 | -- | -- |
| Depreciation & Amortization | 18.7 | -- | -- |
| Operating Income | 12.8 | -- | -- |
| Operating Margin | 4.2% | --% | --% |
| Nonoperating Income | 0.0 | -- | -- |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | 5.0 | -- | -- |
| Income Taxes | 1.7 | -- | -- |
| Net Income After Taxes | 3.4 | 0.0 | 0.0 |
| Continuing Operations | 3.4 | -- | -- |
| Discontinued Operations | 0.0 | -- | -- |
| Total Operations | 3.4 | -- | -- |
| Total Net Income | 3.4 | (0.5) | (142.4) |
| Net Profit Margin | 1.1% | -0.7% | -203.7% |
| Diluted EPS from Total Net Income | 0.11 | -- | -- |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Core Laboratories N.V. Balance Sheet
| Assets | Dec 99 | Dec 94 | Dec 93 |
| Current Assets | |||
| Cash | 18.1 | -- | -- |
| Net Receivables | 81.1 | -- | -- |
| Inventories | 24.5 | -- | -- |
| Other Current Assets | 16.6 | -- | -- |
| Total Current Assets | 140.4 | -- | -- |
| Net Fixed Assets | 64.5 | -- | -- |
| Other Noncurrent Assets | 156.2 | -- | -- |
| Total Assets | 361.1 | -- | -- |
| Liabilities | Dec 99 | Dec 94 | Dec 93 |
| Current Liabilities | |||
| Accounts Payable | 18.2 | -- | -- |
| Short-Term Debt | 1.7 | -- | -- |
| Other Current Liabilities | 27.2 | -- | -- |
| Total Current Liabilities | 47.1 | -- | -- |
| Long-Term Debt | 82.9 | -- | -- |
| Other Noncurrent Liabilities | 22.3 | -- | -- |
| Total Liabilities | 152.2 | -- | -- |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | -- | -- |
| Common Stock Equity | 208.9 | -- | -- |
| Total Equity | 208.9 | -- | -- |
| Shares Outstanding (thou.) | 22,981.1 | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Core Laboratories N.V. Cash Flow Statement
| Dec 99 | Dec 94 | Dec 93 | |
| Net Operating Cash Flow | 4 | -- | -- |
| Net Investing Cash Flow | 10.0 | -- | -- |
| Net Financing Cash Flow | (4.5) | ||
| Net Change in Cash | 10.0 | ||
| Depreciation & Amortization | 18.7 | ||
| Capital Expenditures | (19.1) | ||
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.